CATIONIC OPTHALMIC EMULSION, PRESERVATIVE FREE

Brand name:

• Cationorm®

Pharmaceutical company:

Seqiris (Australia) Pty Ltd

Condition/indication:
(therapeutic use)

• Severe dry eye syndrome

PBAC Submission type:

New listing (Minor)

Comment:

--

Public Summary Document:

PBAC Public Summary Documents – July 2020

Related medicines:

--

Submission received for:

July 2020 PBAC meeting

Opportunity for consumer comment:

Has not yet commenced

PBAC meeting:

Held on 08/07/2020

PBAC outcome published:

Recommended (see PBAC Outcomes)

Notice of intent submitted:

12/01/2021

Lodgement of required documentation:

18/02/2021

Acceptance of complete documentation:

Accepted

Agreement to listing arrangements:

Commenced on 24/05/2021

Status:

Finalised

Government processes:

Commenced on 09/06/2021

Medicine listed on the PBS:

01/08/2021 (see PBS schedule)

---